Moreover, IP3R1 expression is markedly reduced in cisplatin-resistant bladder cancer cell lines and that transient induced over-expression of IP3R1 in resistant cells restored chemo-sensitivity to cisplatin [126]. Here, ITPR1 is linked to urinary bladder carcinoma.